# Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm

> **NCT04695015** · — · UNKNOWN · sponsor: **Peking University** · enrollment: 100 (estimated)

## Conditions studied

- Melanoma (Skin)
- Melanoma in Situ
- Nevus Eye
- Sebaceous Gland Carcinoma of the Eyelid
- Basal Cell Carcinoma
- Squamous Cell Carcinoma in Situ
- Ocular Tumor

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04695015
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-31
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04695015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04695015, "Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04695015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*